| Product Code: ETC7638927 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the top countries exporting rapid acting insulin to Ireland were the USA, UK, Germany, Metropolitan France, and Serbia. The Herfindahl-Hirschman Index (HHI) indicated a high concentration in the market. However, the compound annual growth rate (CAGR) from 2020 to 2024 was -4.18%, with a significant decline in growth rate from 2023 to 2024 at -30.16%. This suggests a challenging market environment for rapid acting insulin import shipments into Ireland, potentially impacted by various factors affecting demand and supply in the industry.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Rapid Acting Insulin Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Rapid Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Rapid Acting Insulin Market - Industry Life Cycle |
3.4 Ireland Rapid Acting Insulin Market - Porter's Five Forces |
3.5 Ireland Rapid Acting Insulin Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Ireland Rapid Acting Insulin Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Ireland Rapid Acting Insulin Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Rapid Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Ireland |
4.2.2 Rising awareness about the benefits of rapid acting insulin |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost of rapid acting insulin products |
4.3.2 Stringent regulations and approval processes for insulin products |
4.3.3 Limited access to healthcare services in certain regions of Ireland |
5 Ireland Rapid Acting Insulin Market Trends |
6 Ireland Rapid Acting Insulin Market, By Types |
6.1 Ireland Rapid Acting Insulin Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Ireland Rapid Acting Insulin Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Ireland Rapid Acting Insulin Market Revenues & Volume, By Lispro Insulin, 2021- 2031F |
6.1.4 Ireland Rapid Acting Insulin Market Revenues & Volume, By Aspart Insulin, 2021- 2031F |
6.1.5 Ireland Rapid Acting Insulin Market Revenues & Volume, By Glulisine Insulin, 2021- 2031F |
6.2 Ireland Rapid Acting Insulin Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Ireland Rapid Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021- 2031F |
6.2.3 Ireland Rapid Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021- 2031F |
6.3 Ireland Rapid Acting Insulin Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Ireland Rapid Acting Insulin Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Ireland Rapid Acting Insulin Market Revenues & Volume, By Drug Stores and Retail Pharmacies, 2021- 2031F |
6.3.4 Ireland Rapid Acting Insulin Market Revenues & Volume, By Online Stores, 2021- 2031F |
7 Ireland Rapid Acting Insulin Market Import-Export Trade Statistics |
7.1 Ireland Rapid Acting Insulin Market Export to Major Countries |
7.2 Ireland Rapid Acting Insulin Market Imports from Major Countries |
8 Ireland Rapid Acting Insulin Market Key Performance Indicators |
8.1 Average time to market for new rapid acting insulin products |
8.2 Number of clinical trials and research studies on rapid acting insulin in Ireland |
8.3 Adoption rate of advanced insulin delivery systems in the market |
9 Ireland Rapid Acting Insulin Market - Opportunity Assessment |
9.1 Ireland Rapid Acting Insulin Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Ireland Rapid Acting Insulin Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Ireland Rapid Acting Insulin Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Rapid Acting Insulin Market - Competitive Landscape |
10.1 Ireland Rapid Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Ireland Rapid Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here